Baxter International Inc
BAX17.690USD
-0.460-2.53%
終値 11/19, 16:00（ET）15分遅れの株価
9.09B時価総額
損失額直近12ヶ月PER
詳細情報 Baxter International Inc 企業名
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Incの企業情報
企業コードBAX
会社名Baxter International Inc
上場日May 15, 1961
最高経営責任者「CEO」Mr. Andrew P. Hider
従業員数38000
証券種類Ordinary Share
決算期末May 15
本社所在地One Baxter Parkway
都市DEERFIELD
証券取引所NYSE Consolidated
国United States of America
郵便番号60015
電話番号12249482000
ウェブサイトhttps://www.baxter.com/
企業コードBAX
上場日May 15, 1961
最高経営責任者「CEO」Mr. Andrew P. Hider
Baxter International Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+45.58%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+77.49%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+206.88%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
7.97K
+912.71%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
--
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.67K
+7.47%
Mr. Alok Sonig
Mr. Alok Sonig
Executive Vice President, Group President - Pharmaceuticals
Executive Vice President, Group President - Pharmaceuticals
127.11K
-2.45%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-14.01%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+25.18%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+31.17%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
他の
391.00M
13.91%
地域別USD
会社名
収益
比率
United States
1.54B
54.66%
International
1.27B
45.34%
事業別
地域別
事業別USD
会社名
収益
比率
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
他の
391.00M
13.91%
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
他の
54.66%
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
他の
54.66%
種類
株主統計
比率
Investment Advisor/Hedge Fund
47.25%
Investment Advisor
44.97%
Hedge Fund
2.90%
Research Firm
2.48%
Pension Fund
1.55%
Insurance Company
1.45%
Bank and Trust
1.22%
Sovereign Wealth Fund
1.14%
Individual Investor
0.46%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1790
516.79M
100.62%
-24.95M
2025Q2
1877
507.74M
98.85%
-23.16M
2025Q1
1934
508.09M
99.01%
-37.41M
2024Q4
1984
501.11M
97.98%
-41.68M
2024Q3
2005
485.40M
95.14%
-42.32M
2024Q2
2042
472.72M
92.77%
-47.98M
2024Q1
2091
469.13M
92.11%
-57.76M
2023Q4
2137
471.69M
92.98%
-44.04M
2023Q3
2123
465.39M
91.91%
-35.52M
2023Q2
2140
458.55M
90.66%
-30.65M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
61.95M
12.06%
+1.13M
+1.85%
Jun 30, 2025
Dodge & Cox
52.12M
10.15%
+662.70K
+1.29%
Jun 30, 2025
Pzena Investment Management, LLC
55.46M
10.8%
+16.12M
+40.98%
Aug 31, 2025
BlackRock Institutional Trust Company, N.A.
29.85M
5.81%
-423.57K
-1.40%
Jun 30, 2025
BlackRock Financial Management, Inc.
18.73M
3.65%
+742.99K
+4.13%
Jun 30, 2025
State Street Investment Management (US)
21.94M
4.27%
+170.66K
+0.78%
Jun 30, 2025
T. Rowe Price Associates, Inc.
21.21M
4.13%
+1.64M
+8.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
12.88M
2.51%
+326.65K
+2.60%
Jun 30, 2025
BlackRock Investment Management, LLC
7.81M
1.52%
+818.08K
+11.70%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
iShares Large Cap Value Active ETF
2.52%
Invesco Raymond James SB-1 Equity ETF
1.86%
SPDR S&P Health Care Equipment ETF
1.56%
Invesco S&P 500 Equal Weight Health Care ETF
1.56%
First Trust Indxx Medical Devices ETF
1.51%
iShares U.S. Medical Devices ETF
1.41%
Franklin US Dividend Booster Index ETF
1.09%
Invesco Zacks Multi-Asset Income ETF
0.99%
Humankind US Stock ETF
0.95%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.71%
詳細を見る
iShares Large Cap Value Active ETF
比率2.52%
Invesco Raymond James SB-1 Equity ETF
比率1.86%
SPDR S&P Health Care Equipment ETF
比率1.56%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.56%
First Trust Indxx Medical Devices ETF
比率1.51%
iShares U.S. Medical Devices ETF
比率1.41%
Franklin US Dividend Booster Index ETF
比率1.09%
Invesco Zacks Multi-Asset Income ETF
比率0.99%
Humankind US Stock ETF
比率0.95%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
比率0.71%
配当金
過去5年間の配当金総支払額は
2.75B
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
May 01, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023
Jun 02, 2023
Jul 03, 2023
Jun 01, 2023
Feb 14, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option
Feb 24, 2023
Apr 03, 2023
Feb 23, 2023
Nov 15, 2022
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022
Dec 02, 2022
Jan 03, 2023
Dec 01, 2022
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
